Copyright
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Feb 16, 2026; 18(2): 114400
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.114400
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.114400
Retrospective comparison of precutting endoscopic band ligation and endoscopic submucosal dissection for small gastric muscularis propria tumors
Yu Ou, Jue Wang, Ming-Feng Liu, Rui Yuan, Shan Li, Liang Deng, Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Jiang Min, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Co-first authors: Yu Ou and Jue Wang.
Co-corresponding authors: Shan Li and Liang Deng.
Author contributions: Ou Y, Wang J, Li S, and Deng L designed and conducted the study and wrote the paper; Ou Y and Wang J contributed equally to this work and were responsible for the study design, data acquisition, data analysis, and manuscript drafting; they contributed equally to this article, and they are the co-first authors of this manuscript; Liu MF, Yuan R, Min J, and Li S provided clinical advice; Li S and Deng L were involved in study design, interpretation of the results, and critical revision of the manuscript, and Li S and Deng L contributed equally to this article and are the co-corresponding authors of this manuscript; all authors thoroughly reviewed and endorsed the final manuscript.
Supported by the Joint Project Foundation of Chongqing Health Commission and Chongqing Scientific and Technological Commission, No. 2021MSXM103; Chongqing Science and Technology Commission Foundation, No. cstc2020jcyj-msxmX0045; and the Natural Science Foundation of Chongqing, No. cstc2020jcyj-msxmX0288.
Institutional review board statement: This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, approval No. K2024-142-01.
Informed consent statement: Owing to the retrospective design of this study, the need for informed consent was exempted by the institutional review board.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets generated or analyzed during the current study are fully contained within this article. Additional details can be obtained from the corresponding author upon reasonable request.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Liang Deng, PhD, Associate Professor, Chief Physician, Director, Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China.
Received: September 19, 2025
Revised: November 9, 2025
Accepted: January 4, 2026
Published online: February 16, 2026
Processing time: 138 Days and 20.2 Hours
Revised: November 9, 2025
Accepted: January 4, 2026
Published online: February 16, 2026
Processing time: 138 Days and 20.2 Hours
Core Tip
Core Tip: This article compared endoscopic submucosal dissection and precutting endoscopic band ligation (EBL) for gastric submucosal tumors < 20 mm originating from the muscularis propria. Both techniques achieved excellent long-term tumor control without recurrence, but precutting EBL demonstrated significant advantages, including a shorter operative time and fewer adverse events. These findings suggest that precutting EBL is a safer, simpler, and more efficient alternative to endoscopic submucosal dissection, warranting further validation in prospective randomized controlled trials.